Physician profile
Ariel Moses
NPI 1235472390
$597.00
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was more than what 79% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $61.91 · 2021: $17.05 · 2022: $21.65 · 2023: $20.17 · 2024: $42.79 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.68 | 2019 | |
| Novo Nordisk INC | $121.35 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $58.08 | 2019-2025 | |
| Amgen INC. | $49.61 | 2025 | Repatha |
| Exact Sciences Corporation | $48.56 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $46.13 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $34.88 | 2020-2021 | |
| Lilly USA, LLC | $33.18 | 2024-2025 | Mounjaro, Zepbound |
| Phathom Pharmaceuticals, INC. | $23.26 | 2025 | Voquezna |
| Abbvie INC. | $21.65 | 2022 | |
| Melinta Therapeutics, LLC | $19.30 | 2019 | |
| Biotronik INC. | $16.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.